Search Tufts Medicine

Displaying 101 - 120 of 147
Articles
May 6, 2020
During these days of the pandemic, hospitals, physician offices and healthcare facilities continue to safely treat patients with non-COVID-19 emergencies and time-sensitive medical needs, especially those with acute and chronic conditions.
clinical trial
...

This clinical investigation is intended to evaluate the safety and effectiveness of Abbott’s AmplatzerTM AmuletTM Left Atrial Appendage (LAA) occluder device (“Amulet device”) compared to commercially available non-vitamin K antagonist oral anticoagulant (NOAC) drugs in patients with non-valvular atrial fibrillation (AF) who are at increased risk for ischemic stroke and who are tolerant of long-term NOAC therapy.
page
...
The mission of the Tufts Women in Medicine and Science (WiMS) Committee is to promote the professional and personal development of women in medicine and science and to advocate for parity for women at our institution.
Articles
December 1, 2019
The Predictive Analytics and Comparative Effectiveness (PACE) Center at Tufts Medical Center’s Institute for Clinical Research and Health Policy Studies, led by Dr. David Kent, has been awarded two research grants by the Patient-Centered Outcomes Research Institute (PCORI).
page
...
The Women’s CV Health Research Group brings together basic scientists from the Molecular Cardiology Research Institute (MCRI) with scientists, clinician investigators and population researchers from diverse Departments at Tufts Medical Center including Internal Medicine, the Mother Infant Research Institute (MIRI), Obstetrics and Gynecology, and Pediatrics with the Tufts Freidman School of Nutrition Science and Policy, Tufts University School of Medicine and School of Public Health, and the Human Nutrition Research Center on Aging (HNRCA) with common interests in studying the unique aspects of Women’s Cardiovascular Health.
clinical trial
...

ASPIRE is a randomized, double-blinded, phase III clinical trial designed to test the efficacy and safety of anticoagulation, compared with aspirin, in patients with a recent ICH and high-risk non-valvular AF (CHA2DS2-VASc score ≥ 2). Seven hundred patients will be enrolled over 3.5 years and followed for study outcomes for a minimum of 12 months and maximum of 36 months. The primary efficacy outcome is any stroke (hemorrhagic or ischemic) or death from any cause. The secondary efficacy outcome is the change in the modified Rankin Scale score.
department
Our team of dedicated physicians provides world-class patient care, research and training. We design the most effective and least invasive treatment plan tailored to each patient's individual needs.
department
The Department of Neurology is at the forefront of treating neurological diseases, uncovering their root causes, and training upcoming neurologists to do the same. When our specialty lies in treating an entire system inclusive of nearly 85 billion neurons, we must collaborate with experts from nearly every branch of medicine to create indisputable improvements in patients’ lives.
Articles
November 1, 2019
According to the Centers for Disease Control and Prevention, insufficient sleep has been linked to the development and management of a number of chronic diseases and conditions, including type 2 diabetes, cardiovascular disease, obesity and depression.
Articles
April 4, 2022
The vascular system, also known as the circulatory system, is comprised of arteries, veins and vessels that carry blood throughout the body.
News
March 15, 2022
For most of her life, Elizabeth Craioveanu, from Hooksett, NH, couldn’t remember ever feeling well for any extended period of time.